InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 6,000 research and publications.
Research title with ★ indicates InBody recommended paper.

Plasma B-Type Natriuretic Peptide Levels May Increase Because of Fat Mass Loss by Metformin or Sodium-Glucose Transporter 2 Inh

Hamasaki et al.
Used Parameters : SMM, BFM, VFA

Publication Year : 2016

Country : Japan

Journal : Journal of Endocrinology and Metabolism

Background: Cardiovascular disease (CVD) is the leading cause of death in type 2 diabetes. Metformin reduces cardiovascular events in obese patients with type 2 diabetes, and sodium-glucose transporter 2 (SGLT2) inhibitors decrease cardiovascular events in type 2 diabetic patients with established CVD. However, the underlying mechanisms behind the cardioprotective effects of metformin and SGLT2 inhibitors are unknown. Methods: Fifteen patients with newly diagnosed type 2 diabetes receiving metformin monotherapy, and seven …
Full text